A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Pegylated Liposomal Doxorubicin
Sponsor: Merck Sharp & Dohme LLC